-
2
-
-
0033550965
-
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: A prospective cohort study
-
Lederberger B, Egger M, Opravil M, et al. Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Lancet. 1999;353:863-868.
-
(1999)
Lancet
, vol.353
, pp. 863-868
-
-
Lederberger, B.1
Egger, M.2
Opravil, M.3
-
3
-
-
0345490968
-
HIV-1-infected antiretroviral-treated patients with prolonged partial viral suppression
-
Tenorio AR, Smith KY, Kuritzkes DR, et al. HIV-1-infected antiretroviral-treated patients with prolonged partial viral suppression. J Acquir Immune Defic Syndr. 2003;34:491-496.
-
(2003)
J Acquir Immune Defic Syndr
, vol.34
, pp. 491-496
-
-
Tenorio, A.R.1
Smith, K.Y.2
Kuritzkes, D.R.3
-
4
-
-
0034070773
-
Sustained CD4+ T cell response after virological failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection
-
Deeks SG, Barbour JD, Martin JN, et al. Sustained CD4+ T cell response after virological failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection. J Infect Dis. 2000;181:946-953.
-
(2000)
J Infect Dis
, vol.181
, pp. 946-953
-
-
Deeks, S.G.1
Barbour, J.D.2
Martin, J.N.3
-
5
-
-
0041326880
-
Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy
-
Hunt PW, Deeks SG, Rodriguez B, et al. Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy. AIDS. 2003;17:1907-1915.
-
(2003)
AIDS
, vol.17
, pp. 1907-1915
-
-
Hunt, P.W.1
Deeks, S.G.2
Rodriguez, B.3
-
6
-
-
0037692997
-
Changes in viral load in people with virological failure who remain on the same HAART regimen
-
Cozzi Lepri A, Phillips AN, Miller V, et al. Changes in viral load in people with virological failure who remain on the same HAART regimen. Antiviral Ther. 2003;8:127-136.
-
(2003)
Antiviral Ther
, vol.8
, pp. 127-136
-
-
Cozzi Lepri, A.1
Phillips, A.N.2
Miller, V.3
-
7
-
-
3042740596
-
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes
-
The PLATO Collaboration. Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes. Lancet. 2004;364:51-62.
-
(2004)
Lancet
, vol.364
, pp. 51-62
-
-
-
8
-
-
9144231780
-
Strong cell-mediated immune responses are associated with the maintenance of low-level viremia in antiretroviral-treated individuals with drug-resistant human immunodeficiency virus type 1
-
Deeks SG, Martin JN, Sinclair E, et al. Strong cell-mediated immune responses are associated with the maintenance of low-level viremia in antiretroviral-treated individuals with drug-resistant human immunodeficiency virus type 1. J Infect Dis. 2004;189:312-321.
-
(2004)
J Infect Dis
, vol.189
, pp. 312-321
-
-
Deeks, S.G.1
Martin, J.N.2
Sinclair, E.3
-
9
-
-
0033790674
-
The impact of protease inhibitor-containing highly active antiretroviral therapy on progression of HIV disease and its relationship to CD4 and viral load
-
Miller V, Sabin CA, Phillips AN, et al. The impact of protease inhibitor-containing highly active antiretroviral therapy on progression of HIV disease and its relationship to CD4 and viral load. AIDS. 2000;14:2129-2136.
-
(2000)
AIDS
, vol.14
, pp. 2129-2136
-
-
Miller, V.1
Sabin, C.A.2
Phillips, A.N.3
-
10
-
-
4444282188
-
Effect of persistent moderate viremia on disease progression during HIV therapy
-
Raffanti SP, Fusco JS, Sherrill BH, et al. Effect of persistent moderate viremia on disease progression during HIV therapy. J Acquir Immune Defic Syndr. 2004;37:1147-1154.
-
(2004)
J Acquir Immune Defic Syndr
, vol.37
, pp. 1147-1154
-
-
Raffanti, S.P.1
Fusco, J.S.2
Sherrill, B.H.3
-
11
-
-
0242529051
-
Insight into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients
-
d'Arminio Monforte A, Cozzi Lepri A, Rezza G, et al. Insight into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. AIDS. 2000;14:499-507.
-
(2000)
AIDS
, vol.14
, pp. 499-507
-
-
D'Arminio Monforte, A.1
Cozzi Lepri, A.2
Rezza, G.3
-
12
-
-
0027122957
-
1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
-
Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR. 1992;41:1-19.
-
(1992)
MMWR
, vol.41
, pp. 1-19
-
-
-
13
-
-
20544443261
-
Update of the drug resistance mutations in HIV-1: 2005
-
Johnson VA, Brun-Vezinet F, Clotet B, et al. Update of the drug resistance mutations in HIV-1: 2005. Top HIV Med. 2005;13:51-57. Available at: http://www.iasusa.org/resistance_mutations/. Accessed June 2005.
-
(2005)
Top HIV Med
, vol.13
, pp. 51-57
-
-
Johnson, V.A.1
Brun-Vezinet, F.2
Clotet, B.3
-
14
-
-
0034687071
-
Clinical outcome of patients with HIV-1 infection according to immunological and virologic response after 6 months of highly active antiretroviral therapy
-
Grabar S, Le Moing V, Goujard C, et al. Clinical outcome of patients with HIV-1 infection according to immunological and virologic response after 6 months of highly active antiretroviral therapy. Ann Intern Med. 2000;133:401-410.
-
(2000)
Ann Intern Med
, vol.133
, pp. 401-410
-
-
Grabar, S.1
Le Moing, V.2
Goujard, C.3
-
15
-
-
0037013040
-
Drug resistance at low viraemia in HIV-1-infected patients with antiretroviral combination therapy
-
Aleman S, Soderbarg K, Visco-Comandini V, et al. Drug resistance at low viraemia in HIV-1-infected patients with antiretroviral combination therapy. AIDS. 2002;16:1039-1044.
-
(2002)
AIDS
, vol.16
, pp. 1039-1044
-
-
Aleman, S.1
Soderbarg, K.2
Visco-Comandini, V.3
-
16
-
-
0032492398
-
CD4 cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART)
-
Kauffman D. CD4 cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART). Lancet. 1998;351:723-724.
-
(1998)
Lancet
, vol.351
, pp. 723-724
-
-
Kauffman, D.1
-
17
-
-
0037083230
-
Predictors of long-term increase in CD4(+) cell counts in human immunodeficiency virus-infected patients receiving a protease inhibitor-containing antiretroviral regimen
-
Le Moing V, Thiebaut R, Chene G, et al. Predictors of long-term increase in CD4(+) cell counts in human immunodeficiency virus-infected patients receiving a protease inhibitor-containing antiretroviral regimen. J Infect Dis. 2002;185:471-480.
-
(2002)
J Infect Dis
, vol.185
, pp. 471-480
-
-
Le Moing, V.1
Thiebaut, R.2
Chene, G.3
-
18
-
-
0032928065
-
Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1
-
Martinez-Picado J, Savara AV, Sutton L, et al. Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1. J Virol. 1999;73:3744-3752.
-
(1999)
J Virol
, vol.73
, pp. 3744-3752
-
-
Martinez-Picado, J.1
Savara, A.V.2
Sutton, L.3
-
19
-
-
0034948377
-
Impaired replication of protease inhibitor-resistant HIV-1 in human thymus
-
Stoddart C, Liegler TJ, Mammano F, et al. Impaired replication of protease inhibitor-resistant HIV-1 in human thymus. Nat Med. 2001;7:712-718.
-
(2001)
Nat Med
, vol.7
, pp. 712-718
-
-
Stoddart, C.1
Liegler, T.J.2
Mammano, F.3
-
20
-
-
9544225179
-
Apoptosis mediated by HIV protease is preceded by the cleavage of Bcl-2
-
Strack PR, Frey MW, Rizzo CJ, et al. Apoptosis mediated by HIV protease is preceded by the cleavage of Bcl-2. Proc Natl Acad Sci USA. 1996;93:9571-9576.
-
(1996)
Proc Natl Acad Sci USA
, vol.93
, pp. 9571-9576
-
-
Strack, P.R.1
Frey, M.W.2
Rizzo, C.J.3
-
21
-
-
19944427724
-
Persistent low viral load on antiretroviral therapy is associated with T cell-mediated control of HIV replication
-
Alatrakchi N, Duvivier C, Costagliola D, et al. Persistent low viral load on antiretroviral therapy is associated with T cell-mediated control of HIV replication. AIDS. 2005;19:25-33.
-
(2005)
AIDS
, vol.19
, pp. 25-33
-
-
Alatrakchi, N.1
Duvivier, C.2
Costagliola, D.3
-
22
-
-
0028943992
-
In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors
-
Condra JH, Schleif WA, Blahy OM, et al. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature. 1995;374:569-571.
-
(1995)
Nature
, vol.374
, pp. 569-571
-
-
Condra, J.H.1
Schleif, W.A.2
Blahy, O.M.3
-
23
-
-
15444377672
-
Ordered accumulation of mutations in HIV protease confers resistance to ritonavir
-
Molla A, Korneyeva M, Gao Q, et al. Ordered accumulation of mutations in HIV protease confers resistance to ritonavir. Nat Med. 1996;2:760-766.
-
(1996)
Nat Med
, vol.2
, pp. 760-766
-
-
Molla, A.1
Korneyeva, M.2
Gao, Q.3
-
24
-
-
3843061223
-
Evolution of resistance to drugs in HIV-1-infected patients failing antiretroviral therapy
-
Kantor R, Shafer RW, Follansbee S, et al. Evolution of resistance to drugs in HIV-1-infected patients failing antiretroviral therapy. AIDS. 2004;18:1503-1511.
-
(2004)
AIDS
, vol.18
, pp. 1503-1511
-
-
Kantor, R.1
Shafer, R.W.2
Follansbee, S.3
-
25
-
-
0035477944
-
Transient relapses ("blips") of plasma HIV RNA levels during HAART are associated with drug resistance
-
Cohen Stuart JW, Wensing AM, Kovacs C, et al. Transient relapses ("blips") of plasma HIV RNA levels during HAART are associated with drug resistance. J Acquir Immune Defic Syndr. 2001;28:105-113.
-
(2001)
J Acquir Immune Defic Syndr
, vol.28
, pp. 105-113
-
-
Cohen Stuart, J.W.1
Wensing, A.M.2
Kovacs, C.3
-
26
-
-
0029028067
-
Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy
-
Larder BA, Kemp SD, Harrigan PR. Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy. Science. 1995;269:696-699.
-
(1995)
Science
, vol.269
, pp. 696-699
-
-
Larder, B.A.1
Kemp, S.D.2
Harrigan, P.R.3
-
27
-
-
3242683096
-
Antiretroviral resistance among HIV-infected persons who have died in British Columbia, in the era of modern antiretroviral therapy
-
Recsky MA, Brumme ZL, Chan KJ, et al. Antiretroviral resistance among HIV-infected persons who have died in British Columbia, in the era of modern antiretroviral therapy. J Infect Dis. 2004;190:285-292.
-
(2004)
J Infect Dis
, vol.190
, pp. 285-292
-
-
Recsky, M.A.1
Brumme, Z.L.2
Chan, K.J.3
-
28
-
-
0032804864
-
Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy
-
Nijhuis M, Schuurman R, de Jong D, et al. Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy. AIDS. 1999;13:2349-2359.
-
(1999)
AIDS
, vol.13
, pp. 2349-2359
-
-
Nijhuis, M.1
Schuurman, R.2
De Jong, D.3
-
29
-
-
2342591920
-
Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia
-
Karlsson AC, Younger SR, Martin JN, et al. Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia. AIDS. 2004;18:981-989.
-
(2004)
AIDS
, vol.18
, pp. 981-989
-
-
Karlsson, A.C.1
Younger, S.R.2
Martin, J.N.3
-
30
-
-
20144370827
-
Interruption of highly active antiretroviral therapy in HIV clinical practice: Results from the ICoNA study
-
D'Arminio Monforte A, Cozzi Lepri A, Phillips A, et al. Interruption of highly active antiretroviral therapy in HIV clinical practice: results from the ICoNA study. J Acquir Immune Defic Syndr. 2005;38:407-416.
-
(2005)
J Acquir Immune Defic Syndr
, vol.38
, pp. 407-416
-
-
D'Arminio Monforte, A.1
Cozzi Lepri, A.2
Phillips, A.3
-
31
-
-
0037169269
-
Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremia
-
Deeks SG, Barbour JD, Grant RM, et al. Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremia. AIDS. 2002;16:201-207.
-
(2002)
AIDS
, vol.16
, pp. 201-207
-
-
Deeks, S.G.1
Barbour, J.D.2
Grant, R.M.3
|